Literature DB >> 33825180

Apoptotic cell death induced by dendritic derivatives of aminolevulinic acid in endothelial and foam cells co-cultures.

Mariela A Céspedes1, Daniel A Saénz1, Gustavo H Calvo1, Marina González2, Alexander J MacRobert3, Sinan Battah4, Adriana G Casas5, Gabriela M Di Venosa6.   

Abstract

Photodynamic therapy (PDT) is an effective procedure for the treatment of lesions diseases based on the selectivity of a photosensitising compound with the ability to accumulate in the target cell. Atherosclerotic plaque is a suitable target for PDT because of the preferential accumulation of photosensitisers in atherosclerotic plaques. Dendrimers are hyperbranched polymers conjugated to drugs. The dendrimers of ALA hold ester bonds that inside the cells are cleaved and release ALA, yielding PpIX production. The dendrimer 6m-ALA was chosen to perform this study since in previous studies it induced the highest porphyrin macrophage: endothelial cell ratio (Rodriguez et al. in Photochem Photobiol Sci 14:1617-1627, 2015). We transformed Raw 264.7 macrophages to foam cells by exposure to oxidised LDLs, and we employed a co-culture model of HMEC-1 endothelial cells and foam cells to study the affinity of ALA dendrimers for the foam cells. In this work it was proposed an in vitro model of atheromatous plaque, the aim was to study the selectivity of an ALA dendrimer for the foam cells as compared to the endothelial cells in a co-culture system and the type of cell death triggered by the photodynamic treatment. The ALA dendrimer 6m-ALA showed selectivity PDT response for foam cells against endothelial cells. A light dose of 1 J/cm2 eliminate foam cells, whereas less than 50% of HMEC-1 is killed, and apoptosis cell death is involved in this process, and no necrosis is present. We propose the use of ALA dendrimers as pro-photosensitisers to be employed in photoangioplasty to aid in the treatment of obstructive cardiovascular diseases, and these molecules can also be employed as a theranostic agent.

Entities:  

Keywords:  Aminolevulinic acid; Atheromas; Dendrimers; Macrophages; Photodynamic therapy; Tumour

Year:  2021        PMID: 33825180     DOI: 10.1007/s43630-021-00025-x

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  39 in total

1.  Aminolevulinic acid dendrimers in photodynamic treatment of cancer and atheromatous disease.

Authors:  L Rodriguez; P Vallecorsa; S Battah; G Di Venosa; G Calvo; L Mamone; D Sáenz; M C Gonzalez; A Batlle; A J MacRobert; A Casas
Journal:  Photochem Photobiol Sci       Date:  2015-06-11       Impact factor: 3.982

2.  Synthesis and biological studies of 5-aminolevulinic acid-containing dendrimers for photodynamic therapy.

Authors:  S H Battah; C E Chee; H Nakanishi; S Gerscher; A J MacRobert; C Edwards
Journal:  Bioconjug Chem       Date:  2001 Nov-Dec       Impact factor: 4.774

Review 3.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

Review 4.  Photodynamic therapy in dermatology beyond non-melanoma cancer: An update.

Authors:  Xiang Wen; Yong Li; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-06-21       Impact factor: 3.631

Review 5.  Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results.

Authors:  J C Kennedy; S L Marcus; R H Pottier
Journal:  J Clin Laser Med Surg       Date:  1996-10

6.  Photoradiation therapy for the treatment of malignant tumors.

Authors:  T J Dougherty; J E Kaufman; A Goldfarb; K R Weishaupt; D Boyle; A Mittleman
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

7.  Clinical uses of 5-aminolaevulinic acid in photodynamic treatment and photodetection of cancer: A review.

Authors:  Adriana Casas
Journal:  Cancer Lett       Date:  2020-06-10       Impact factor: 8.679

8.  Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy.

Authors:  Tao Zhou; Sinan Battah; Francesca Mazzacuva; Robert C Hider; Paul Dobbin; Alexander J MacRobert
Journal:  Bioconjug Chem       Date:  2018-10-05       Impact factor: 4.774

9.  Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates.

Authors:  Sinan Battah; Sherina Balaratnam; Adriana Casas; Sophie O'Neill; Christine Edwards; Alcira Batlle; Paul Dobbin; Alexander J MacRobert
Journal:  Mol Cancer Ther       Date:  2007-03       Impact factor: 6.261

Review 10.  Porphyrin photosensitizers in photodynamic therapy and its applications.

Authors:  Jiayuan Kou; Dou Dou; Liming Yang
Journal:  Oncotarget       Date:  2017-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.